Trial · NCT02460081
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Ankle-brachial Index (ABI) | Approximately 1 year | The ankle brachial index is the ratio of the measurement of the blood pressure in the ankle and the arm. |
| Primary | Transcutaneous oxygen measurement (TCOM) | Approximately 1 year | Transcutaneous oxygen measurement measures the oxygen flow in vessels beneath the skin surface |
| Secondary | Adverse Events (AEs) | Approximatly 1 year | Number of participants with adverse events |
| Secondary | Ulcer closure | Approximatly 1 year | Ulcer closure is defined as skin closure of the index ulcer without drainage or need for dressing. |
| Secondary | Complete wound closure of the index ulcer | Approximatly 1 year | Complete wound closure is defined as closure of the index ulcer and retaining wound closure for the subsequent 4 weeks. |
| Secondary | Number of ulcers | Approximatly 1 year | The total number of non index ulcers will be collected |
| Secondary | Size of ulcers | Approximatly 1 year | The area of each ulcer will be collected. |
| Secondary | 50% closure of the index ulcer | Approximatly 1 year | The time to when the ulcer has closed 50 % will be collected. |
| Secondary | Time to major amputation (above the ankle) of treated leg | Approximatly 1 year | The time to a major amputation (above the ankle) will be collected. |
| Secondary | Wagner Grading Scale | Approximatly 1 year | The extent of the ulcer will be collected using a standard scale for ulcer assessment. |
| Secondary | Rutherford Criteria | Approximately 1 year | The extent of symptoms associated with decreased limb perfusion will be collected using a standard scale. |
| Secondary | Leg Rest Pain Score Visual Analog Scale (VAS) | Approximately 1 year | Pre and Post treatment Limb Pain level will be assessed using a VAS |
| Secondary | Patient Global Impression of Change in Neuropathy (PGICN) | Approximately 1 year | Subjects will be assessed for symptoms of diabetic neuropathy using a standard scale. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02460081/registered